MedPath

Lidocaine

Lidocaine hydrochloride and epinephrine injection, USP (Lidocaine HCl 2% and Epinephrine 1:50,000 Injection) (Lidocaine HCl 2% and Epinephrine 1:100,000 Injection)

Approved
Approval ID

1afeb9e0-1f86-43d8-ad37-c69ca783c39e

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Dec 21, 2017

Manufacturers
FDA

CareStream Health, Inc.

DUNS: 793169512

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Lidocaine Hydrochloride and Epinephrine Bitartrate

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code31382-898
Application NumberANDA088390
Product Classification
M
Marketing Category
C73584
G
Generic Name
Lidocaine Hydrochloride and Epinephrine Bitartrate
Product Specifications
Route of AdministrationSUBCUTANEOUS
Effective DateDecember 13, 2017
FDA Product Classification

INGREDIENTS (7)

Edetate DisodiumInactive
Quantity: 0.25 mg in 1 mL
Code: 7FLD91C86K
Classification: IACT
WaterInactive
Code: 059QF0KO0R
Classification: IACT
Lidocaine HydrochlorideActive
Quantity: 20 mg in 1 mL
Code: V13007Z41A
Classification: ACTIR
Epinephrine BitartrateActive
Quantity: 0.01 mg in 1 mL
Code: 30Q7KI53AK
Classification: ACTIM
Potassium MetabisulfiteInactive
Quantity: 1.2 mg in 1 mL
Code: 65OE787Q7W
Classification: IACT
Sodium ChlorideInactive
Quantity: 6.5 mg in 1 mL
Code: 451W47IQ8X
Classification: IACT
Sodium HydroxideInactive
Code: 55X04QC32I
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Lidocaine - FDA Drug Approval Details